|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Renin Activity, Plasma
MessageThis test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
Test Code
10537
CPT Codes
84244
Preferred Specimen
3 mL plasma collected froman EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Instructions
Centrifuge and separate blood at room temperature. Avoid refrigerated temperatures. When submitting catheterization studies, it is recommended that the referring laboratory retain a portion of each sample.Patient should be ambulatory for 30 minutes prior to draw. Patient should be on a moderate sodium diet duringcollection. Avoid refrigeration to eliminate cryoactivation of prorenin to renin. 'Patient should refrain from taking medications, preferably 3 weeks prior to draw
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
Room temperature: 24 hours
Refrigerated: 24 hours
Frozen: 28 days
Refrigerated: 24 hours
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature; Received refrigerated
Methodology
Angiotensin I Generation ;Immunoassay
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
p.m. Daily
Report Available
2-4 days
Reference Range
0.25-5.82 ng/mL/h
Clinical Significance
See Renin Assays and Renin Direct in the Cardiovascular section of Test Application and Interpretation.
Performing Laboratory
| Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
| 33608 Ortega Highway |
| San Juan Capistrano, CA 92675-2042 |
